Sep 22, 2026 · Science & Research Daily Digest
Science, space, biomedicine, and climate research highlights compiled for Sep 22, 2026, with summaries, links, and brief commentary.
I. Space & Deep Space
1. MeerKAT reports first radio emission localized to an exoplanet: β Pictoris b field ≳1.25 kG (Exoplanets)
Summary:
Teams from the Center for Astrophysics | Harvard & Smithsonian and the University of Oregon used South Africa’s MeerKAT array for four observing epochs in 2025–2026 of the β Pictoris system (~64 light-years away), detecting rapid, recurring bursts plus persistent emission at about 0.85–3.5 GHz with ~40%–70% circular polarization. Astrometric ties to quasars place the source on planet b, with only about a six-in-a-million chance of a stellar mislocation. The authors interpret the signal as electron-cyclotron maser auroral emission, implying a local magnetic field of at least ~1.25 kilogauss—the first such direct field-strength claim for an exoplanet. The work is an arXiv preprint pending peer review; multiple outlets covered it on Sep 22.
Links:
- arXiv — Discovery of radio emission from the exoplanet β Pictoris b
- Universe Magazine — Magnetic field of an exoplanet measured directly for the first time
Commentary:
Exoplanet magnetism moves from dynamo guesses to a measurable frequency ceiling—but preprint status still demands hard checks on stellar contamination and harmonic alternatives.
2. Perseverance: Jezero’s Margin Unit records at least three water–rock episodes (Mars geology)
Summary:
Using SuperCam data from NASA’s Perseverance rover, a team reporting in Communications Earth & Environment finds that high-elevation exposures of Jezero Crater’s Margin Unit are slow-cooled, olivine-rich igneous rock rather than simple shoreline sediment, while lower exposures below a hypothesized paleolake terrace show complex alteration. At least three episodes are identified: neutral-to-alkaline, CO₂-rich fluids forming carbonate ridges; later lower-pH fluids remobilizing carbonate and precipitating silica; and late hydrothermal fluids depositing fluorite-bearing calcium-sulfate veins (~25 cm thick locally). NASA highlighted the results on Sep 21, noting the sequence can be ordered but not yet dated.
Links:
- NASA — NASA Discovery Reveals Complex Water Systems on Early Mars
- Communications Earth & Environment — Lake- and groundwater-associated alteration of the Margin unit
Commentary:
The “lake-shore carbonate” story becomes a multi-stage groundwater–hydrothermal record—useful for sampling priorities, still blocked by chronology for biosignature claims.
3. ESA issues “A call to boost European space exploration”: LEO autonomy, Moon, Mars stepping stones (Space policy)
Summary:
On Sep 22, ESA published that Member States endorsed “A call to boost European space exploration” at the Sep 9 International Space Summit in Paris. The Call prioritizes three goals: secure European access to and presence in low Earth orbit after the ISS era; strengthen Europe’s role on and around the Moon via cooperation plus targeted autonomy; and treat LEO and the Moon as stepping stones toward Mars. Director General Josef Aschbacher said Europe is charting greater LEO autonomy and a more competitive space sector. Options go to the Intermediate Ministerial Meeting in Rome on Dec 15.
Links:
Commentary:
This is a political roadmap, not a launch manifest—Europe’s “meaningful” lunar seat still hinges on December budgets and Moon Base role talks with NASA.
II. Biomedicine & Health
4. FDA approves AQNEURSA: first therapy indicated for ataxia in ataxia-telangiectasia (Rare disease)
Summary:
The U.S. FDA approved IntraBio’s levacetylleucine (AQNEURSA) for ataxia in adults and children with ataxia-telangiectasia (A-T) weighing ≥15 kg—the first approved A-T treatment worldwide—and the drug’s second U.S. indication after neurological manifestations of Niemann-Pick disease type C. Pivotal support came from Phase 3 crossover trial IB1001-303 in 73 genetically confirmed patients aged 4–50: at 12 weeks, SARA improved by about 1.9 points versus placebo and functional SARA by about 0.6 points (The Lancet Neurology, July 2026). FDA content is dated Sep 18; company and media coverage clustered Sep 21–22.
Links:
- FDA — FDA Approves Therapy to Treat Ataxia in Patients with Ataxia-Telangiectasia
- BioSpace — IntraBio Announces U.S. FDA Approval of AQNEURSA for Ataxia-Telangiectasia
Commentary:
A long-empty indication finally has a labeled option—but mechanism remains incompletely known, and durability plus access below the weight cutoff are the next gates.
5. FDA updates WINREVAIR label with HYPERION: 76% lower clinical-worsening risk in newly diagnosed PAH (Cardiopulmonary)
Summary:
On Sep 22, Merck said the FDA approved a U.S. label update for sotatercept-csrk (WINREVAIR) incorporating Phase 3 HYPERION data. In adults with PAH diagnosed within ~12 months, WHO FC II/III, at intermediate-to-high progression risk (N=320, 1:1), adding WINREVAIR to background therapy cut clinical-worsening risk by 76% versus placebo (HR 0.24, 95% CI 0.14–0.41, p<0.0001); first events occurred in 10.6% (17/160) versus 36.9% (59/160). Mean time since diagnosis was about 7.2 months. Concurrent ERS guidelines give a “strong” recommendation for add-on WINREVAIR in eligible adults.
Links:
- Merck — FDA Approves Update to the Label for WINREVAIR Based on HYPERION
- BioSpace — WINREVAIR HYPERION label update
Commentary:
The label shifts the narrative from late add-on to year-one use—the real test is whether dual/triple background-therapy clinics actually start earlier, not another positive headline.
6. Columbia: engineered probiotics deliver in-tumor chemo + immunotherapy; ~43% complete regression in mouse CRC (Oncology)
Summary:
Nicholas Arpaia and colleagues at Columbia engineered probiotic E. coli Nissle 1917 to colonize tumors, express matrix-anchored cytosine deaminase that converts nontoxic 5-FC into 5-FU locally, and co-release an IL-15 superagonist plus a PD-L1-blocking nanobody while deleting the bacterial preTA operon that detoxifies 5-FU. In mouse colorectal (MC38) and melanoma models, the combination slowed tumors and extended survival; in CRC, 3 of 7 mice showed complete regression (~43%) with lasting protection against rechallenge. Coverage tied to Science Translational Medicine appeared via Medical Xpress and ScienceAlert on Sep 22.
Links:
- Medical Xpress — Engineered probiotic bacteria produce cancer drugs inside tumors
- ScienceAlert — Engineered Probiotic Wipes Out 43% of Colorectal Tumors in Mice
Commentary:
Moving the pharmacy into the tumor core is compelling—mouse complete-response rates still sit far from human tumor heterogeneity and microbiome safety bars.
7. Stanford: AI narrows 1.7 million polymers to 10 antimicrobial candidates; all beat expectations against E. coli (Anti-infectives)
Summary:
Eric Appel, Shoshana Williams and colleagues at Stanford School of Engineering report in Matter a cross-molecular active-learning pipeline that screened ~1.7 million polyacrylamide candidates for peptide-like antimicrobial properties, then synthesized and tested the top 10. All performed above expectations against E. coli (Gram-negative), and one was especially active against biofilms. The authors argue the route could extend to other double-membraned pathogens and help address resistance. phys.org covered the work on Sep 22.
Links:
- phys.org — Bacteria-killing polymers—a new class of antibiotic?
- Matter — Cross-molecular active learning for the discovery of antimicrobial polyacrylamides
Commentary:
AI compressed an ocean of polymers into a wet-lab shortlist—toxicity, PK, and in vivo infection models still separate hits from drugs, but the chemical space entry is real.
III. Climate, Energy & Environment
8. University of Delaware: Ni(OH)₂ symmetric-battery DAC pilot at ~0.83 MWh per tonne CO₂ (Negative emissions)
Summary:
Yushan Yan’s University of Delaware team, with Israel’s RepAir DAC, describe in Nature Energy (Sep 22) a hydroxide-exchange-membrane Ni(OH)₂ symmetric battery for electrochemical direct air capture. A 25 cm² lab cell ran durability tests beyond 5,000 hours; a 9 × 300 cm² pilot stack operated 48 hours at ~132 kJ per mol CO₂ (~0.83 MWh per tonne), ~0.19 mol m⁻² h⁻¹ flux (~75 kg m⁻² yr⁻¹), while meeting a ~300 Pa pressure-drop target. The paper sketches a learning-rate path toward below ~US$100 per tonne.
Links:
- Nature Energy — A Ni(OH)₂ symmetric battery cell for hydroxide exchange membrane-based DAC
- Scienmag — Nickel Hydroxide Battery Cell Pulls CO₂ from Air at Record Low Energy Cost
Commentary:
Reporting pressure drop alongside tonne-scale energy is closer to engineering reality than lab joules alone—scale-up and full life-cycle cost remain the referees.
9. Nanjing University: ambient-air perovskite–silicon tandem reaches 33.0% certified efficiency (Photovoltaics)
Summary:
Nanjing University researchers report in Nature Sustainability a hole-transport copolymer, PNCC, enabling blade-coated perovskite devices under ambient air. Single-junction cells reached 26.6% PCE (26.5% certified) and retained ~99.8% of initial efficiency after ~1,200 hours of continuous light soaking; two-terminal perovskite–silicon tandems hit 33.3% champion / 33.0% independently certified efficiency (18 devices averaged ~32.0%). pv magazine covered the ambient-processing implications on Sep 21–22.
Links:
- Nature Sustainability — Scalable ambient fabrication of single-junction and perovskite–silicon tandem solar cells
- pv magazine — Chinese scientists build 33.3%-efficient perovskite-silicon tandem processed in ambient air
Commentary:
Skipping the glovebox matters more to factories than another 0.1-point lab record—watch large-area yield and outdoor degradation next.
10. Optimized SO₂ cuts in China can sharply curb near-term ERFaci warming (Climate policy)
Summary:
Collaborators including Nanjing University of Information Science & Technology and Pacific Northwest National Laboratory model, in Nature Communications (Sep 22), spatially optimized SO₂ reductions under a China carbon-neutral pathway and their effect on aerosol–cloud effective radiative forcing (ERFaci). Targeting highly polluted regions limits the 2020–2040 regional-average ERFaci rise from more than ~0.89 W m⁻² to less than ~0.13 W m⁻² and weakens the 2060 ERFaci increase by about two-thirds. The authors argue clean-air and climate goals must be co-designed to avoid unintended short-term warming.
Links:
- PNNL — Strategizing Emission Cuts in China to Mitigate Short-term Warming from Clean Air Policies
- Nature Communications — doi:10.1038/s41467-026-72190-5
Commentary:
“Which smog to cut first” becomes a climate lever—still hostage to aerosol–cloud parameterization, the field’s largest uncertainty.
IV. Fundamental Research & Cross-Cutting Frontiers
11. USTC: relativistic quantum position verification over 2 km fiber at ~74.3 m precision (Quantum information)
Summary:
Guan-Jie Fan-Yuan and colleagues at the University of Science and Technology of China report in Nature Physics a coherent-state relativistic quantum position-verification protocol demonstrated over an ~2 km fiber link. Honest provers are distinguished from adversaries under the security model, with ~0.27% error and a maximum response delay of ~247.8 ns, corresponding to ~74.3 m spatial precision (roughly building scale). The authors call it the first complete experimental demonstration of secure quantum position verification under realistic loss, error, and latency. phys.org featured the work on Sep 22.
Links:
- phys.org — Quantum protocol securely verifies a device's position using stations 2 km apart
- Nature Physics — Relativistic position verification with coherent states
Commentary:
Binding “are you where you claim?” to relativity plus quantum constraints is a new security brick—still far from city-scale location services.
12. Planetary Science Institute: RNA World “sweet spot” around 4.33 billion years ago (Origins of life)
Summary:
Oleg Abramov and colleagues at the Planetary Science Institute report in Nature Communications (Sep 22) a 3D impact-heating model combined with biomolecule thermal-stability limits to time when Hadean Earth became suitable for an RNA World. Conditions look favorable between about 4.4 and 4.3 billion years ago, with an optimum near 4.33 Ga; a gap of roughly 130 million years (uncertainty up to ~240 Myr) may separate that window from LUCA estimates near 4.2 Ga. Live Science detailed the same day how impacts both sterilize and create near-surface hydrothermal habitats.
Links:
Commentary:
This is a thermal suitability window, not fossil proof that RNA life existed—tightening the geological clock on origin narratives.
Today's Summary
- Exoplanet magnetism gets a first direct radio “tape measure” (β Pic b), while Jezero’s Margin Unit is rewritten as a multi-episode water–rock history.
- Rare disease and PAH: AQNEURSA opens an A-T indication; WINREVAIR’s label now carries year-one HYPERION evidence.
- Climate tech advances on two fronts: electrochemical DAC pilots near ~0.83 MWh/t and ambient perovskite–silicon tandems at 33.0% certified.
- On the fundamentals side, quantum position verification leaves the lab fiber, and the RNA World window tightens around ~4.33 Ga.
Daily Framing:
Today in the science cycle was a “measure-and-translate” day—hard numbers on exoplanet fields, Martian water history, DAC/PV, and rare-disease labels landed together.
This digest is compiled from real-time search results and is for reference only.